Fairvoy Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.65M Buy
25,093
+20,325
+426% +$2.81M 0.73% 37
2026
Q2
$613K Buy
4,768
+326
+7% +$38.2K 0.12% 128
2026
Q1
$534K Sell
4,442
-29
-0.6% -$3.35K 0.13% 137
2025
Q4
$471K Buy
4,471
+348
+8% +$32.7K 0.11% 122
2025
Q3
$346K Sell
4,123
-742
-15% -$61.1K 0.08% 148
2025
Q2
$385K Sell
4,865
-390
-7% -$31K 0.1% 133
2025
Q1
$472K Sell
5,255
-12,202
-70% -$1.14M 0.13% 112
2024
Q4
$1.74M Buy
+17,457
New +$1.8M 0.46% 58

Other funds holding MRK

Fairvoy Private Wealth's MRK Position: Q3 2026 in Review

Fairvoy Private Wealth increased its Merck (MRK) stake by 426% in Q3 2026, buying an estimated $2.81M and bringing the position to 25,093 shares worth $3.65M. The position accounts for 0.73% of the portfolio, ranked #37.

Fairvoy Private Wealth first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Fairvoy Private Wealth held 25,093 shares of Merck worth $3.65M as of Q3 2026.
  • Fairvoy Private Wealth bought 20,325 Merck shares in Q3 2026, an estimated $2.81M.
  • Merck made up 0.73% of Fairvoy Private Wealth's portfolio in Q3 2026, its #37 holding.
  • Fairvoy Private Wealth first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.